The Quantum Blue rapid Point-of-Care (POC) calprotectin test is a sensitive, non-invasive tool to pre-select patients requiring colonoscopy for confirmation of organic bowel disease (IBD). Quantitative results for calprotectin concentration (in ug/g stool) are available within 12 minutes and are very comparable to the established Bühlmann Calprotectin ELISA.

The Quantum Blue Rapid POC assay combines the ease and speed of lateral flow technology (using a highly specific monoclonal antibody to Calprotectin), with full quantitation by means of a small, telephone sized reading device. The Quantum Blue calprotectin reader analyzes the signal intensity from the test and control line to give a quantitative value and is standardized with the Bühlmann Calprotectin ELISA.

This diagnostic tool enables a rapid gatekeeper strategy based on calprotectin levels in patient stool samples to support the physician's decision on whether to prepare patients for colonoscopy or to treat them for the symptoms associated with Irritable Bowel Syndrome (IBS).